Nan Fung Trinity »

Trevi Therapeutics shares owned by Nan Fung Trinity

Quarter-by-quarter ownership of Trevi Therapeutics (TRVI) shares owned by Nan Fung Trinity from 13F filings

Historical chart of Nan Fung Trinity investment in Trevi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Trevi Therapeutics held by Nan Fung Trinity consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trevi Therapeutics by Nan Fung Trinity

Quarter filed Position value Share count Share price at filing
2025-09-30 $820k 90k 9.15

More positions owned by Nan Fung Trinity

Ishares Msci Sth Kor Etf (EWY)
Ishares Msci Brazil Etf (EWZ)
Amcor Ord (AMCR)
Amazon (AMZN)
Spdr Series Trust S&p Regl Bkg (KRE)
Baidu Spon Adr Rep A (BIDU)
NVIDIA Corporation (NVDA)
America Movil Sab De Cv Spon Ads Rp Cl B (AMX)
Intuit (INTU)
PPG Industries (PPG)
Ishares Msci Thailnd Etf (THD)
Zoom Communications Cl A (ZM)
Ishares Tr Core S&p Mcp Etf (IJH)
Ge Healthcare Technologies I Common Stock (GEHC)
Spdr Series Trust S&p Bk Etf (KBE)

View all positions for Nan Fung Trinity

Top funds holding Trevi Therapeutics

NEA Management Company
Frazier Life Sciences Management
BlackRock
Rubric Capital Management
Vanguard Group
Viking Global Investors
Vivo Capital
Marshall Wace
Alliancebernstein
MPM Oncology Impact Management
OrbiMed Advisors
FMR
Wellington Management Company
Octagon Capital Advisors
Affinity Asset Advisors

View all funds holding Trevi Therapeutics